Professional Overview
Mark Newman is a seasoned business development executive currently serving as Senior Director Business Development at Maze Therapeutics in CA, United States. He leverages his expertise in business development, strategic planning, and project finance to drive growth and innovation within the biotechnology and pharmaceutical industries.
Experience Summary
Current Role
As Senior Director Business Development at Maze Therapeutics, Mark is responsible for leading business development initiatives, fostering strategic partnerships, and identifying new opportunities for growth. His key responsibilities include developing and executing business strategies, managing cross-functional teams, and negotiating partnerships. Under his leadership, the company has experienced significant growth and expansion into new markets.
Career Progression
Mark's career trajectory spans over a decade, with notable previous roles including Director Business Development and Associate Director Business Development at Maze Therapeutics, Consultant at NewCo at Third Rock Ventures, and various positions at Genentech, including Senior Manager and Manager of Research and Early Development Project Finance. His career growth is marked by increasing responsibilities, promotions, and a strong track record of achievements.
Academic Background
Mark holds degrees from Stanford University Graduate School of Business and Bowdoin College. Although specific details of his education are not available, his academic background has equipped him with a strong foundation in business and strategic planning.
Areas of Expertise
Mark's expertise areas include:
- Business development and strategic planning
- Project finance and management
- Partnership development and negotiation
- Cross-functional team leadership
- Industry analysis and market research
Professional Impact
Throughout his career, Mark has made significant contributions to the biotechnology and pharmaceutical industries. His work at Maze Therapeutics has driven business growth, and his experience at Genentech has informed his approach to project finance and management. Although specific projects and initiatives are not detailed, his professional impact is evident in his career progression and current role.
Conclusion
Mark Newman is a seasoned business development executive with a strong track record of driving growth and innovation within the biotechnology and pharmaceutical industries. His current focus as Senior Director Business Development at Maze Therapeutics is on leading business development initiatives and fostering strategic partnerships. With his expertise, leadership capabilities, and industry experience, Mark offers a unique value proposition to his organization and the industry at large.
